Over 2.5 million Americans are addicted to opioids but fewer than 50% of private sector treatment programs offer medications for Opioid Use Disorder (OUD) and only one-third of patients in those programs receive them.
Traditional treatment, which begins with detox and relies on lifelong abstinence, is no match for today’s opioid addiction. Like other medical conditions, to stabilize and manage opioid use disorder requires a medical model, using one of three FDA-approved medications. These medications significantly diminish cravings and reduce the risk of relapse.